Why Marzetti’s New York Bakery launch matters for investors
Marzetti (MZTI) just broadened its New York Bakery lineup with Baked Bites frozen snacks, Cheesy Focaccia and new Garlic Bread loaves, targeting convenient, premium options across snacking and family meals.
This expansion opens fresh shelf space for Marzetti in the frozen snacks aisle and also deepens its reach at the dinner table, which gives investors a clearer view of how management is trying to grow branded retail sales.
Marzetti’s push into frozen snacks and premium bread formats comes at a time of weak momentum, with the share price down 10.86% over the past 30 days, the year-to-date share price return declining 39.42%, and the 1-year total shareholder return falling 39.75%.
Scan how Marzetti compares with other food manufacturers that are trying to spark fresh interest through product launches by reviewing the curated 19 high quality undiscovered gems in this corner of the market.
After a near 40% slide in the past year, Marzetti now sits at a very different price than when the New York Bakery story began. Is most of the upside still in front of you, or already in the rear-view mirror as a valuation call today?
Most Popular Narrative: 32% Undervalued
Marzetti closed at $99.69, while the most followed narrative anchors fair value at $146.60 using a 7.24% discount rate. This frames the recent share price slide as a valuation gap rather than just sentiment damage.
The launch of newly licensed and branded products (like national rollout of Texas Roadhouse dinner rolls and new core brand innovations) is expected to drive retail volume growth and further premiumization, directly supporting top-line revenue and, given the mix shift, potentially expanding net margins. Expanded marketing investments and data-driven digital initiatives are improving household penetration rates and repeat purchases across core brands, positioning the company to capture a larger share of the continued shift toward at-home meal preparation and fueling sustainable revenue growth.
See why 2 investors see Marzetti as 32% undervalued.
Result: Fair Value of $146.60 (UNDERVALUED)
Still, the Marzetti story can change quickly if health focused shoppers move faster toward fresh, clean label options, or if private label bread and sauces squeeze pricing power.
Find out about the key risks to this Marzetti narrative.
Next Steps
If this mix of optimism and caution around Marzetti leaves you undecided, rely on the numbers instead and move quickly to test your own thesis with 3 key rewards.
Looking for more Marzetti-sized investment ideas?
Do not stop with Marzetti. Use the Simply Wall St screener to quickly surface fresh opportunities that fit the mix of quality, value and resilience you want.
- Target upside with companies that combine strong fundamentals and attractive pricing by reviewing the curated 28 high quality undervalued stocks before others move in.
- Prioritise balance sheet strength and financial resilience by focusing on the list of solid balance sheet and fundamentals (25 results) so you are not caught off guard in tougher conditions.
- Hunt for lesser known opportunities with quality metrics on your side by scanning the 31 resilient stocks with low risk scores before the rest of the market pays attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com